duloxetine hydrochloride has been researched along with fluoxetine in 68 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (7.35) | 18.2507 |
2000's | 15 (22.06) | 29.6817 |
2010's | 34 (50.00) | 24.3611 |
2020's | 14 (20.59) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Cistarelli, JM; Gobert, A; Millan, MJ; Rivet, JM | 1 |
Lakoski, JM; Smith, JE | 2 |
Cistarelli, L; Gobert, A; Melon, C; Millan, MJ; Rivet, JM | 1 |
Lucki, I; Rénéric, JP | 1 |
Demitrack, MA; Goldstein, DJ; Lu, Y; Mallinckrodt, C | 1 |
Audia, JE; Katofiasc, MA; Nissen, J; Thor, KB | 1 |
Hemrick-Luecke, SK; Iyengar, S; Simmons, RM; Webster, AA; Xu, JY | 1 |
Greist, J; Mallinckrodt, CH; McNamara, RK; Raskin, J; Rayamajhi, JN | 1 |
Fava, M; Hazen, E | 1 |
Eckert, L; Lançon, C | 1 |
Cookson, J; Desaiah, D; Gilaberte, I; Kajdasz, DK | 1 |
Eastwood, BJ; Jones, CK; Need, AB; Shannon, HE | 1 |
Detke, MJ; Faries, DE; Mallinckrodt, CH; Meyers, AL; Prakash, A | 1 |
Detke, MJ; Ossanna, MJ; Pritchett, YL; Swindle, RW; Thase, ME; Xu, J | 1 |
Detke, MJ; Fava, M; Houston, JP; Mallinckrodt, CH; Prakash, A; Swindle, R | 1 |
Carvalho, LA; Gorenstein, C; Markus, RP; Moreno, R; Pariante, C | 1 |
Apfeldorf, WJ; Cullen, CE; Eide, CE; Lu, BY; Williams, CC | 1 |
Baker, SJ; Boyce-Rustay, JM; Decker, MW; Honore, P; Kohnken, R; Simler, GH; Wensink, EJ; Zhong, C | 1 |
Argento, V; Blagodatny, M; Liu, PT; Skudlarska, B | 1 |
Lucassen, PJ; Marlatt, MW; van Praag, H | 1 |
Kourti, PV; Samanidou, VF | 1 |
Chapman, A; Delivuk, M; Gartlehner, G; Gaynes, BN; Kaminski, A; Thaler, K | 1 |
Chen, NH; Li, J; Liu, Y; Sun, JD; Yuan, YH | 1 |
Kovatsi, L; Livanos, A; Njau, S; Pantazidou, K; Samanidou, V | 1 |
Fan, DS; Guo, L; Ji, CX; Li, W; Liang, ZL; Xu, RM; Zhang, JJ | 1 |
Barbui, C; Cipriani, A; Furukawa, TA; Koesters, M; Nosè, M; Omori, IM; Purgato, M; Trespidi, C | 1 |
Clarke, G; Cryan, JF; Dinan, TG; Griffin, BT; O'Brien, FE | 1 |
Martin, WJ; Obedencio, GP; Shen, F; Smith, JA; Tsuruda, PR | 1 |
Fang, Q; Hu, YH; Li, S; Wu, FF; Wu, J; Xie, LJ; Yang, LY; Zhou, JN | 1 |
Atkinson, SD; Bangs, ME; Emslie, GJ; March, JS; Pangallo, BA; Prakash, A; Zhang, Q | 1 |
Bangs, ME; Emslie, GJ; March, JS; Pangallo, BA; Prakash, A; Zhang, Q | 1 |
Calow, AD; Fernández, E; Whiting, A | 1 |
Gu, S; Guo, J; Luo, H; Qu, W; Tang, Q | 1 |
Buchwald, SL; Shi, SL | 1 |
Hu, Q; Imamoto, T; Liu, Y; Zhang, W; Zhang, Z | 1 |
Dueñas, H; Haro, JM; Hong, J; Moneta, MV; Montgomery, W; Novick, D; Peng, X | 1 |
Bangs, ME; Emslie, GJ; March, JS; Pangallo, BA; Prakash, A; Wells, TG; Zhang, Q | 1 |
Berquist, MD; Mooney-Leber, SM; Pehrson, AL; Porter, JH; Porter, NP; Prus, AJ | 1 |
Chen, F; Sánchez, C; Waller, JA | 1 |
Ceci, A; Doods, H; Hu, B; Treede, RD | 1 |
Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X | 1 |
Gulinello, M; Li, Y; Sanchez, C | 1 |
Chekroud, AM; Gueorguieva, R; Krystal, JH | 1 |
Chen, M; Hoshino, H; Obata, H; Saito, S; Yang, Y | 1 |
Jiao, Y; Liang, Y; Lin, J; Qu, H; Sun, Y; Xu, J; Zhao, C | 1 |
Gilron, I; Moore, RA; Shum, B; Thorpe, J; Wiffen, PJ | 1 |
Jiao, X; Li, Y; Liang, M; Tang, B; Wang, X; Xiao, Y; Xie, X | 1 |
Carleton, BC; Etminan, M; Guo, MY; Kezouh, A; Kim, DD; Procyshyn, RM; Samii, A | 1 |
Buchanan, GF; Dayton, KG; Kruse, SW; Purnell, BS; Rosner, JI | 1 |
Bellin, G; Ferroni, L; Gardin, C; Pavan, C; Vindigni, V; Zavan, B | 1 |
Feng, S; Gu, J; Jiang, X; Tang, S; Wang, L; Zheng, L | 1 |
Barata, C; Gómez-Canela, C; Marcé, RM; Martínez-Jerónimo, F; Rovira García, X | 1 |
Chapman, A; Gartlehner, G; Gaynes, BN; Nussbaumer-Streit, B; Probst, T; Sönnichsen, A; Thaler, K; Winkler, D | 1 |
Bonci, A; Marino, RAM; McDevitt, RA; Tejeda, HA | 1 |
Badcock, PB; Bailey, AP; Cox, GR; Hetrick, SE; McKenzie, JE; Meader, N; Merry, SN; Moller, CI; Sharma, V | 1 |
Haas, DM; Marks, C; Quinney, SK; Silvola, R; Teal, E | 1 |
Bonds, JA; Brooker, SM; Kessler, JA; McGuire, TL; Peng, CY; Rawat, R; Tsai, YH; Tunc-Ozcan, E | 1 |
Athreya, AP; Bobo, WV; Croarkin, PE; Emslie, GJ; Kennard, BD; Leffler, JM; Mayes, T; McKean, AJ; Rackley, SJ; Romanowicz, M; Shekunov, J; Trivedi, M; Vande Voort, JL; Wang, L; Weinshilboum, RM | 1 |
Chen, B; Gao, N; Hu, G; Li, Y; Wang, R; Xu, T; Zhang, X | 1 |
Bracke, F; Frieling, H; Leffler, A | 1 |
Chen, B; Fang, L; Qian, J; Sun, W; Tong, S; You, H | 1 |
Chen, KY; Li, RY | 1 |
Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Okuya, M; Sakuma, K | 1 |
Eap, CB; Favre, L; Frantz, J; Garin, P; Vandenberghe, F; Vionnet, N | 1 |
Asadi-Pooya, AA; Firouzabadi, N; Kashkooli, M; Malekpour, M; Zamiri, B | 1 |
Cao, Q; Rao, Y; Yang, R; Zhao, J | 1 |
11 review(s) available for duloxetine hydrochloride and fluoxetine
Article | Year |
---|---|
Duloxetine compared with fluoxetine and venlafaxine: use of meta-regression analysis for indirect comparisons.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Duloxetine Hydrochloride; Fluoxetine; Humans; Randomized Controlled Trials as Topic; Regression Analysis; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder.
Topics: Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Depressive Disorder, Major; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Fluoxetine; Humans; Paroxetine; Placebos; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome | 2007 |
Second-generation antidepressants for seasonal affective disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Morpholines; Phototherapy; Randomized Controlled Trials as Topic; Reboxetine; Seasonal Affective Disorder; Thiophenes | 2011 |
Duloxetine versus other anti-depressive agents for depression.
Topics: Antidepressive Agents; Citalopram; Cyclohexanols; Depression; Desvenlafaxine Succinate; Dibenzothiazepines; Duloxetine Hydrochloride; Fluoxetine; Humans; Paroxetine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Thiophenes; Venlafaxine Hydrochloride | 2012 |
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Evidence-Based Medicine; Fluoxetine; Humans; Imipramine; Mianserin; Mirtazapine; Nortriptyline; Paroxetine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sertraline; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2016 |
Combination pharmacotherapy for the treatment of fibromyalgia in adults.
Topics: 5-Hydroxytryptophan; Acetaminophen; Adult; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Benzodiazepines; Carisoprodol; Drug Therapy, Combination; Duloxetine Hydrochloride; Fibromyalgia; Fluoxetine; Humans; Magnesium; Malates; Melatonin; Monoamine Oxidase Inhibitors; Muscle Relaxants, Central; Pregabalin; Randomized Controlled Trials as Topic | 2018 |
Second-generation antidepressants for treatment of seasonal affective disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Bias; Citalopram; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Morpholines; Observational Studies as Topic; Phototherapy; Placebos; Quality of Life; Randomized Controlled Trials as Topic; Reboxetine; Seasonal Affective Disorder; Thiophenes; Treatment Outcome | 2021 |
New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Topics: Adolescent; Antidepressive Agents; Bias; Child; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mirtazapine; Network Meta-Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicidal Ideation; Venlafaxine Hydrochloride; Vilazodone Hydrochloride; Vortioxetine | 2021 |
Efficacy and safety of different antidepressants and anticonvulsants in central poststroke pain: A network meta-analysis and systematic review.
Topics: Amitriptyline; Anticonvulsants; Antidepressive Agents; Carbamazepine; Duloxetine Hydrochloride; Fluoxetine; Gabapentin; Humans; Lamotrigine; Multicenter Studies as Topic; Network Meta-Analysis; Neuralgia; Pregabalin; Randomized Controlled Trials as Topic; Vitamins | 2022 |
Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
Topics: Adult; Amitriptyline; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Fluvoxamine; Humans; Mirtazapine; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Reboxetine; Sertraline; Venlafaxine Hydrochloride; Vortioxetine | 2023 |
Efficacy and tolerability of antidepressant drugs in treatment of depression in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Escitalopram; Fluoxetine; Humans; Imipramine; Network Meta-Analysis; Paroxetine; Sertraline; Venlafaxine Hydrochloride | 2022 |
10 trial(s) available for duloxetine hydrochloride and fluoxetine
Article | Year |
---|---|
Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Blood Pressure; Body Weight; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome | 2002 |
Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Europe; Female; Fluoxetine; Humans; Male; Middle Aged; Nausea; Paroxetine; Prevalence; Severity of Illness Index; Sex Factors; Thiophenes; Time Factors; United States | 2004 |
Treatment benefits of duloxetine in major depressive disorder as assessed by number needed to treat.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome | 2006 |
Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram).
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Thiophenes; Treatment Outcome | 2007 |
Effect of antidepressants on melatonin metabolite in depressed patients.
Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Hypericum; Male; Melatonin; Middle Aged; Plant Extracts; Severity of Illness Index; Thiophenes; Treatment Outcome | 2009 |
A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder.
Topics: Adolescent; Antidepressive Agents; Child; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Suicidal Ideation; Suicide; Thiophenes; Treatment Outcome | 2014 |
A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder.
Topics: Adolescent; Antidepressive Agents; Child; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Suicidal Ideation; Suicide; Thiophenes; Treatment Outcome | 2014 |
Effects of olanzapine-fluoxetine combination treatment of major depressive disorders on the quality of life during acute treatment period.
Topics: Adult; Benzodiazepines; Depressive Disorder, Major; Drug Administration Schedule; Drug Combinations; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Quality of Life; Sleep Wake Disorders; Somatoform Disorders; Thiophenes | 2014 |
Acute and longer-term safety results from a pooled analysis of duloxetine studies for the treatment of children and adolescents with major depressive disorder.
Topics: Adolescent; Antidepressive Agents; Child; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Suicidal Ideation | 2015 |
Trajectories of relapse in randomised, placebo-controlled trials of treatment discontinuation in major depressive disorder: an individual patient-level data meta-analysis.
Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Meta-Analysis as Topic; Middle Aged; Patient Dropouts; Placebo Effect; Protective Factors; Recurrence; Severity of Illness Index; Time Factors; Treatment Outcome; Withholding Treatment | 2017 |
47 other study(ies) available for duloxetine hydrochloride and fluoxetine
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Buspirone enhances duloxetine- and fluoxetine-induced increases in dialysate levels of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely moving rats.
Topics: Animals; Buspirone; Dopamine; Duloxetine Hydrochloride; Fluoxetine; Frontal Lobe; Male; Microdialysis; Norepinephrine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists; Thiophenes | 1997 |
Electrophysiological effects of fluoxetine and duloxetine in the dorsal raphe nucleus and hippocampus.
Topics: Analysis of Variance; Animals; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Electrophysiology; Fluoxetine; Hippocampus; Infusions, Intravenous; Iontophoresis; Male; Neurons; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Thiophenes | 1997 |
Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Biogenic Monoamines; Dopamine; Duloxetine Hydrochloride; Fluoxetine; Frontal Lobe; Male; Norepinephrine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Thiophenes | 1997 |
Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Cyclopropanes; Desipramine; Duloxetine Hydrochloride; Fluoxetine; Male; Milnacipran; Motor Activity; Rats; Rats, Sprague-Dawley; Thiophenes | 1998 |
Cellular electrophysiological effects of chronic fluoxetine and duloxetine administration on serotonergic responses in the aging hippocampus.
Topics: Aging; Animals; Antidepressive Agents; Drug Administration Schedule; Duloxetine Hydrochloride; Electrophysiology; Evoked Potentials; Female; Fluoxetine; Hippocampus; Pyramidal Cells; Rats; Rats, Inbred F344; Serotonin; Thiophenes | 1998 |
Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats.
Topics: Acetic Acid; Administration, Intravesical; Adrenergic Uptake Inhibitors; Animals; Cats; Cyclohexanols; Duloxetine Hydrochloride; Electromyography; Female; Fluoxetine; Humans; Methiothepin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Thiophenes; Urethra; Urinary Bladder; Venlafaxine Hydrochloride | 2002 |
Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.
Topics: Acute Disease; Amines; Amitriptyline; Animals; Conscious Sedation; Cyclohexanecarboxylic Acids; Cyclohexanols; Cyclopropanes; Disease Models, Animal; Drug Therapy, Combination; Duloxetine Hydrochloride; Fluoxetine; Formaldehyde; Gabapentin; gamma-Aminobutyric Acid; Male; Methyltyrosines; Milnacipran; Neuromuscular Junction; Norepinephrine; p-Chloroamphetamine; Pain; Paroxetine; Rats; Rats, Sprague-Dawley; Serotonin; Thiophenes; Venlafaxine Hydrochloride | 2004 |
Successful treatment with duloxetine in a case of treatment refractory bulimia nervosa: a case report.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Bulimia; Drug Resistance; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2006 |
Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.
Topics: Adrenergic Uptake Inhibitors; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain Chemistry; Carrageenan; Cyclohexanols; Desipramine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Duloxetine Hydrochloride; Edema; Fluoxetine; Hot Temperature; Hyperalgesia; Male; Norepinephrine; Paroxetine; Pressure; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Thiophenes; Venlafaxine Hydrochloride | 2006 |
Simple options for improving signal detection in antidepressant clinical trials.
Topics: Antidepressive Agents; Citalopram; Clinical Trials as Topic; Databases, Factual; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Duloxetine Hydrochloride; Fluoxetine; Likelihood Functions; Models, Statistical; Paroxetine; Personality Inventory; Placebo Effect; Psychometrics; Reproducibility of Results; Research Design; Signal Detection, Psychological; Thiophenes; Treatment Outcome | 2007 |
Antidepressant-induced sweating alleviated by aripiprazole.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Dopamine Agonists; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Hyperhidrosis; Middle Aged; Piperazines; Quinolones; Sweating; Thiophenes | 2008 |
Comparison of mechanical allodynia and the affective component of inflammatory pain in rats.
Topics: Analgesics, Non-Narcotic; Animals; Behavior, Animal; Celecoxib; Central Nervous System Agents; Diclofenac; Disease Models, Animal; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Escape Reaction; Fluoxetine; Inflammation; Male; Motor Activity; Neuropsychological Tests; Pain; Pain Measurement; Physical Stimulation; Pyrazoles; Rats; Rats, Sprague-Dawley; Scopolamine; Sulfonamides; Thiophenes; Treatment Outcome | 2010 |
Serotonin syndrome in an octogenarian after switch from fluoxetine to duloxetine.
Topics: Aged, 80 and over; Duloxetine Hydrochloride; Fluoxetine; Humans; Male; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Thiophenes | 2009 |
Comparison of neurogenic effects of fluoxetine, duloxetine and running in mice.
Topics: Animals; Behavior, Animal; Cell Proliferation; Cell Survival; Duloxetine Hydrochloride; Female; Fluoxetine; Hippocampus; Mice; Mice, Inbred C57BL; Motor Activity; Neurogenesis; Neuronal Plasticity; Neurons; Physical Conditioning, Animal; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2010 |
Rapid HPLC method for the simultaneous monitoring of duloxetine, venlaflaxine, fluoxetine and paroxetine in biofluids.
Topics: Chromatography, High Pressure Liquid; Cyclohexanols; Duloxetine Hydrochloride; Fluoxetine; Humans; Limit of Detection; Paroxetine; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Thiophenes; Venlafaxine Hydrochloride | 2009 |
Gap junction dysfunction in the prefrontal cortex induces depressive-like behaviors in rats.
Topics: Analysis of Variance; Animals; Carbenoxolone; Connexin 43; Disease Models, Animal; Duloxetine Hydrochloride; Electroshock; Exploratory Behavior; Fluoxetine; Food Deprivation; Food Preferences; Gap Junctions; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Hormone Antagonists; Inhibition, Psychological; Isoquinolines; Male; Microscopy, Electron, Transmission; Mifepristone; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Restraint, Physical; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Social Isolation; Stress, Psychological; Sucrose; Sweetening Agents; Swimming; Thiophenes | 2012 |
A simple HPLC method for the simultaneous determination of two selective serotonin reuptake inhibitors and two serotonin-norepinephrine reuptake inhibitors in hair, nail clippings, and cerebrospinal fluid.
Topics: Adrenergic Uptake Inhibitors; Biological Transport; Cerebrospinal Fluid; Chromatography, High Pressure Liquid; Cyclohexanols; Duloxetine Hydrochloride; Fluoxetine; Hair; Humans; Nails; Norepinephrine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride | 2012 |
Evaluation of the anti-ulcerogenic activity of the antidepressants duloxetine, amitriptyline, fluoxetine and mirtazapine in different models of experimental gastric ulcer in rats.
Topics: Amitriptyline; Animals; Anti-Ulcer Agents; Antidepressive Agents; Disease Models, Animal; Duloxetine Hydrochloride; Fluoxetine; Immersion; Indomethacin; Male; Mianserin; Mirtazapine; Rats; Rats, Sprague-Dawley; Reserpine; Restraint, Physical; Stomach Ulcer; Stress, Psychological; Thiophenes; Water | 2012 |
Human P-glycoprotein differentially affects antidepressant drug transport: relevance to blood-brain barrier permeability.
Topics: Amitriptyline; Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Capillary Permeability; Dogs; Duloxetine Hydrochloride; Fluoxetine; Humans; Imipramine; Madin Darby Canine Kidney Cells; Mianserin; Mirtazapine; Thiophenes; Transfection | 2013 |
Relative contributions of norepinephrine and serotonin transporters to antinociceptive synergy between monoamine reuptake inhibitors and morphine in the rat formalin model.
Topics: Analgesia; Animals; Atomoxetine Hydrochloride; Biogenic Monoamines; Chromatography, Liquid; Drug Synergism; Duloxetine Hydrochloride; Fluoxetine; Formaldehyde; Morphine; Morpholines; Neurotransmitter Uptake Inhibitors; Nociceptive Pain; Norepinephrine Plasma Membrane Transport Proteins; Ondansetron; Propylamines; Rats; Rotarod Performance Test; Serotonin Plasma Membrane Transport Proteins; Tandem Mass Spectrometry; Thiophenes | 2013 |
Copper(II)-catalyzed enantioselective hydrosilylation of halo-substituted alkyl aryl and heteroaryl ketones: asymmetric synthesis of (R)-fluoxetine and (S)-duloxetine.
Topics: Catalysis; Copper; Duloxetine Hydrochloride; Fluoxetine; Ketones; Molecular Conformation; Organometallic Compounds; Stereoisomerism; Thiophenes | 2014 |
Total synthesis of fluoxetine and duloxetine through an in situ imine formation/borylation/transimination and reduction approach.
Topics: Chemistry, Organic; Duloxetine Hydrochloride; Fluoxetine; Imines; Thiophenes | 2014 |
Copper-catalysed selective hydroamination reactions of alkynes.
Topics: Alkynes; Amination; Amines; Atomoxetine Hydrochloride; Benzhydryl Compounds; Catalysis; Copper; Cresols; Duloxetine Hydrochloride; Fluoxetine; Phenylpropanolamine; Propylamines; Stereoisomerism; Thiophenes; Tolterodine Tartrate | 2015 |
ZnCl2 -promoted asymmetric hydrogenation of β-secondary-amino ketones catalyzed by a P-chiral Rh-bisphosphine complex.
Topics: Amination; Amino Alcohols; Atomoxetine Hydrochloride; Catalysis; Chlorides; Coordination Complexes; Duloxetine Hydrochloride; Fluoxetine; Hydrogenation; Ketones; Phosphines; Propylamines; Rhodium; Stereoisomerism; Thiophenes; Zinc Compounds | 2015 |
Real-world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia.
Topics: Adult; Asia, Eastern; Citalopram; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Middle Aged; Pain; Paroxetine; Prospective Studies; Quality of Life; Regression Analysis; Remission Induction; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 2016 |
The antidepressant drugs fluoxetine and duloxetine produce anxiolytic-like effects in a schedule-induced polydipsia paradigm in rats: enhancement of fluoxetine's effects by the α2 adrenoceptor antagonist yohimbine.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Anti-Anxiety Agents; Antidepressive Agents; Disease Models, Animal; Drinking; Drinking Water; Duloxetine Hydrochloride; Fluoxetine; Food Deprivation; Male; Polydipsia; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Yohimbine | 2015 |
Vortioxetine promotes maturation of dendritic spines in vitro: A comparative study in hippocampal cultures.
Topics: Animals; Antidepressive Agents; Cells, Cultured; Dendritic Spines; Duloxetine Hydrochloride; Fluoxetine; Hippocampus; Ketamine; Piperazines; Rats, Sprague-Dawley; Serotonin and Noradrenaline Reuptake Inhibitors; Sulfides; Synapses; Vortioxetine | 2016 |
Duloxetine and 8-OH-DPAT, but not fluoxetine, reduce depression-like behaviour in an animal model of chronic neuropathic pain.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic Neurons; Analgesics; Animals; Antidepressive Agents; Behavior, Animal; Chronic Disease; Depression; Duloxetine Hydrochloride; Fluoxetine; Hyperalgesia; Male; Neuralgia; Norepinephrine; Rats, Wistar; Serotonergic Neurons; Serotonin | 2016 |
Distinct Antidepressant-Like and Cognitive Effects of Antidepressants with Different Mechanisms of Action in Middle-Aged Female Mice.
Topics: Aging; Animals; Antidepressive Agents; Cognition; Cohort Studies; Depression; Duloxetine Hydrochloride; Female; Fluoxetine; Memory; Mice, Inbred C57BL; Piperazines; Psychotropic Drugs; Random Allocation; Space Perception; Sulfides; Vilazodone Hydrochloride; Visual Perception; Vortioxetine | 2017 |
Spinal dopaminergic involvement in the antihyperalgesic effect of antidepressants in a rat model of neuropathic pain.
Topics: Amitriptyline; Analgesics; Animals; Antidepressive Agents; Cyclopropanes; Disease Models, Animal; Dopamine; Dopamine Antagonists; Duloxetine Hydrochloride; Fluoxetine; Hyperalgesia; Male; Milnacipran; Neuralgia; Pain Threshold; Rats, Sprague-Dawley; Spinal Cord Dorsal Horn; Sulpiride | 2017 |
Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis.
Topics: Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Depression; Depressive Disorder; Doxepin; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Morpholines; Paroxetine; Patient Acceptance of Health Care; Reboxetine; Selective Serotonin Reuptake Inhibitors; Stroke; Treatment Outcome | 2017 |
Evaluating Drug-Induced Liver Injury and Its Remission via Discrimination and Imaging of HClO and H
Topics: Antidepressive Agents; Chemical and Drug Induced Liver Injury; Duloxetine Hydrochloride; Fluorescent Dyes; Fluoxetine; Humans; Hydrogen Sulfide; Hypochlorous Acid; Molecular Structure; Optical Imaging; Protons | 2018 |
Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological Study.
Topics: Antidepressive Agents; Basal Ganglia Diseases; Bupropion; Case-Control Studies; Citalopram; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Pharmacoepidemiology; Sertraline; United States; Venlafaxine Hydrochloride | 2018 |
Effect of monoamine reuptake inhibition and α
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Citalopram; Duloxetine Hydrochloride; Electroshock; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Prazosin; Reboxetine; Seizures; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin and Noradrenaline Reuptake Inhibitors; Sudden Unexpected Death in Epilepsy | 2019 |
Effects of novel antidepressant drugs on mesenchymal stem cell physiology.
Topics: Adipocytes; Adipogenesis; Adipose Tissue; Adult; Antidepressive Agents; Cell Differentiation; Cell Proliferation; Cells, Cultured; Duloxetine Hydrochloride; Fluoxetine; Gene Expression; Humans; Mesenchymal Stem Cells; Osteocytes; Osteogenesis; Osteoporosis; Selective Serotonin Reuptake Inhibitors; Young Adult | 2019 |
In-vitro and in situ assessment of the efflux of five antidepressants by breast cancer resistance protein.
Topics: Amitriptyline; Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Biological Transport; Blood-Brain Barrier; Brain; Cell Line, Tumor; Duloxetine Hydrochloride; Fluoxetine; Humans; Mirtazapine; Neoplasm Proteins; Rats; Rats, Sprague-Dawley; Sertraline | 2019 |
Analysis of neurotransmitters in Daphnia magna affected by neuroactive pharmaceuticals using liquid chromatography-high resolution mass spectrometry.
Topics: Animals; Aquatic Organisms; Chromatography, High Pressure Liquid; Daphnia; Duloxetine Hydrochloride; Fluoxetine; Mass Spectrometry; Models, Animal; Neurotransmitter Agents; Sertraline; Venlafaxine Hydrochloride; Water Pollutants, Chemical | 2019 |
Serotonergic inhibition of responding for conditioned but not primary reinforcers.
Topics: Animals; Citalopram; Conditioning, Classical; Cues; Dorsal Raphe Nucleus; Duloxetine Hydrochloride; Female; Fluoxetine; Gene Knockout Techniques; Male; Mice; Mice, Inbred C57BL; Motivation; Neurons; Reward; Selective Serotonin Reuptake Inhibitors; Serotonin; Tryptophan Hydroxylase | 2021 |
Comparing newborn outcomes after prenatal exposure to individual antidepressants: A retrospective cohort study.
Topics: Antidepressive Agents; Bupropion; Citalopram; Duloxetine Hydrochloride; Escitalopram; Female; Fluoxetine; Humans; Infant, Newborn; Pregnancy; Prenatal Exposure Delayed Effects; Retrospective Studies; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2021 |
Hippocampal BMP signaling as a common pathway for antidepressant action.
Topics: Aging; Animals; Anti-Anxiety Agents; Antidepressive Agents; Behavior, Animal; Bone Morphogenetic Proteins; Dentate Gyrus; Duloxetine Hydrochloride; Electroconvulsive Therapy; Fluoxetine; Ganglia, Spinal; Hippocampus; Mice, Inbred C57BL; Mice, Transgenic; Neurogenesis; Signal Transduction; Stress, Psychological; Trazodone; Vilazodone Hydrochloride | 2021 |
Evidence for machine learning guided early prediction of acute outcomes in the treatment of depressed children and adolescents with antidepressants.
Topics: Adolescent; Antidepressive Agents; Artificial Intelligence; Child; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Fluoxetine; Humans; Machine Learning; Treatment Outcome | 2022 |
Inhibitory effects of fluoxetine and duloxetine on the pharmacokinetics of metoprolol in vivo and in vitro.
Topics: Animals; Chromatography, Liquid; Cytochrome P-450 CYP2D6; Duloxetine Hydrochloride; Fluoxetine; Humans; Metoprolol; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry | 2022 |
Antidepressants Are Poor Inhibitors of Heat-Evoked Ion Currents Mediated by TRPM2.
Topics: Adenosine Diphosphate Ribose; Amitriptyline; Animals; Antidepressive Agents; Citalopram; Duloxetine Hydrochloride; Fluoxetine; HEK293 Cells; Hot Temperature; Humans; Ketamine; Lidocaine; Mice; Paroxetine; Pregabalin; Sertraline; TRPM Cation Channels | 2022 |
Enantioseparation of N-methyl duloxetine, duloxetine, and fluoxetine by countercurrent chromatography using anionic β-cyclodextrin as chiral selector.
Topics: Anions; beta-Cyclodextrins; Countercurrent Distribution; Duloxetine Hydrochloride; Ethers; Fluoxetine; Phosphates; Solvents; Stereoisomerism | 2022 |
The Influence of a Roux-en-Y Gastric Bypass on Plasma Concentrations of Antidepressants.
Topics: Adult; Antidepressive Agents; Duloxetine Hydrochloride; Escitalopram; Female; Fluoxetine; Gastric Bypass; Humans; Obesity, Morbid; Prospective Studies; Retrospective Studies; Trazodone | 2023 |
FKBP5 blockade may provide a new horizon for the treatment of stress-associated disorders: An in-silico study.
Topics: Citalopram; Clomipramine; Duloxetine Hydrochloride; Fluoxetine; Humans; Sertraline; United States | 2023 |